NovaBridge Biosciences (NBP) Amortization of Deferred Charges (2020)
NovaBridge Biosciences (NBP) posted quarterly Amortization of Deferred Charges of $414943.7 for Q3 2020.
NovaBridge Biosciences (NBP) Amortization of Deferred Charges (2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Amortization of Deferred Charges for 1 consecutive years, with $414943.7 the latest figure, recorded in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | NovaBridge Biosciences | 397.57 Mn | 397.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 414,943.75 |
| Sep 30, 2020 | 414,943.75 |